Rhythm Pharmaceuticals shares surge 28% on AstraZeneca's $10 billion acquisition proposal
RYTM Rhythm Pharmaceuticals Inc
$113.95 +0.01%
View chart & analysis → - 1The Wall Street Journal reported that AstraZeneca made a $10 billion acquisition proposal for Rhythm Pharmaceuticals.
- 2AstraZeneca's proposed acquisition price per share last month was $124.
- 3Rhythm Pharmaceuticals closed at $110.68 on Wednesday, representing a 28% increase in share price.
So what's the key point?
AstraZeneca proposed to buy Rhythm Pharmaceuticals for $10 billion. Rhythm Pharmaceuticals' share price rose by 28% following this news.
Source WSJ +2 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.